tirzepatide with peptides GLP-2 (40mg vials) Order Tirzepatide (30 mg) |

One caveat on reputation

Fatigue Some people experience fatigue during the first few weeks of tirzepatide use, regardless of dose

The administration starts with a low 2.5 mg dose for the first four weeks

Whether this increases or decreases oral dryness compared to injections is not yet well studied

Concerningly, unexpected significant ADEs were revealed, with the top six strongest signal ADEs ranked by the EBGM being injection site coldness (n = 86, ROR 155.64, PRR 155.47, IC 71.39, EBGM 6.16), injection site injury (n = 86, ROR 155.64, PRR 155.47, IC 71.39, EBGM 6.16), accidental underdose (n = 470, ROR 58.11, PRR 57.52, IC 40.2, EBGM 5.33), extra dose administered (n = 2222, ROR 49.7, PRR 48.32, IC 35.51, EBGM 5.15), injection site laceration (n = 19, ROR 46.67, PRR 46.66, IC 34.61, EBGM 5.11), and starvation ketoacidosis (n = 7, ROR 45.56, PRR 45.56, IC 34.01, EBGM 5.09)

Best for: People who want the most aggressive weight loss option and are willing to accept higher side effect rates and the current lack of FDA approval